Fleming Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Fleming Pharmaceuticals's estimated annual revenue is currently $9.4M per year.(i)
  • Fleming Pharmaceuticals's estimated revenue per employee is $201,000

Employee Data

  • Fleming Pharmaceuticals has 47 Employees.(i)
  • Fleming Pharmaceuticals grew their employee count by -2% last year.

Fleming Pharmaceuticals's People

NameTitleEmail/Phone
1
Executive Administrative AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2720.7M84607%N/AN/A
#2
$13.5M673%N/AN/A
#3
$9.2M46-4%N/AN/A
#4
$19.9M9960%N/AN/A
#5
$48.4M24111%N/AN/A
#6
$1.9M1958%N/AN/A
#7
$6M30-9%N/AN/A
#8
$13.1M6512%N/AN/A
#9
$1137.5M35373%$97MN/A
#10
$18.5M92-13%N/AN/A
Add Company

What Is Fleming Pharmaceuticals?

Specializing in the development and manufacture of innovative prescription and over-the-counter (OTC) therapies, privately held Fleming Pharmaceuticals is the proud maker of MAGONATE®, NEPHROCAPS®, NEPHROCAPS® QT, ThyroShield®, ProBarimin QT® and the OCEAN® Nasal Care line of products. Established in 1960, the company has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and obstetrics/gynecology. Based in the greater St. Louis area, our fully integrated headquarter facility houses state-of-the-art liquid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.

keywords:N/A

N/A

Total Funding

47

Number of Employees

$9.4M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.7M472%N/A
#2
$8.7M482%N/A
#3
$35M48109%N/A
#4
$8.9M490%N/A
#5
$6.8M494%N/A